lipoxin a4 has been researched along with transforming growth factor beta in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Akhmetshina, A; Dees, C; Distler, JH; Distler, O; Krönke, G; Lang, V; Palumbo, K; Reich, N; Schett, G; Scholtysek, C; Uderhardt, S; Zerr, P | 1 |
| Caetano, GF; Faccioli, LH; Frade, MAC; Galvão, AF; Leite, MN; Paula-Silva, FWG; Pereira, PAT; Reis, MB | 1 |
| Heinrich, MA; Kuninty, PR; Prakash, J; Schnittert, J; Storm, G | 1 |
| Bai, Y; He, Z; Jiang, H; Li, L; Wang, J; Yang, M | 1 |
| Cho, J; Han, SY; Kim, H; Kim, JM; Lee, YS; Park, SH | 1 |
| Alexanderson-Rosas, E; Amezcua-Guerra, LM; Azar-Manzur, F; Bojalil, R; Brianza-Padilla, M; Carvajal-Juárez, I; González-Pacheco, H; Gopar-Nieto, R; Hernández, S; López-Mora, E; Márquez-Velasco, R; Martínez-Sánchez, C; Massó, F; Paez-Arenas, A; Sandoval, J; Venegas-Román, A | 1 |
| Hafez, HM; Hammady, SH; Ibrahim, MA; Ibrahim, YF; Rifaai, RA; Waz, S | 1 |
7 other study(ies) available for lipoxin a4 and transforming growth factor beta
| Article | Year |
|---|---|
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Bleomycin; Cells, Cultured; Dermis; Eicosanoids; Fibroblasts; Fibrosis; Lipoxins; Mesoderm; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Protein Serine-Threonine Kinases; Scleroderma, Systemic; Transforming Growth Factor beta | 2012 |
Lipoxin A4 encapsulated in PLGA microparticles accelerates wound healing of skin ulcers.
Topics: Animals; Cytokines; Interleukin-1beta; Interleukin-6; Lactic Acid; Lipoxins; Male; Neutrophils; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Skin Ulcer; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing | 2017 |
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cellular Reprogramming; Collagen Type I; Combined Modality Therapy; Gene Expression Regulation, Neoplastic; Humans; Lipoxins; Mice; Pancreatic Neoplasms; Pancreatic Stellate Cells; Paracrine Communication; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2018 |
Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Docosahexaenoic Acids; Fibrosis; Inflammation Mediators; Lipoxins; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2019 |
LXA
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Fibrosis; Humans; Lipoxins; Lung; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Radiation; Radiotherapy; Receptor Cross-Talk; Receptors, Formyl Peptide; Receptors, Lipoxin; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2020 |
Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Patients With Refractory Angina Pectoris and Heart Failure.
Topics: Aged; Angina Pectoris; Angiopoietin-Like Protein 1; Angiopoietin-like Proteins; Coronary Artery Disease; Cytokines; Endothelial Progenitor Cells; Extracorporeal Shockwave Therapy; Female; Heart Failure; Humans; Interleukin-18; Interleukin-1beta; Lipoxins; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Prospective Studies; Severity of Illness Index; Stroke Volume; Transforming Growth Factor beta; Treatment Outcome; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left; Walk Test | 2021 |
Dose-dependent ameliorating effect of lipoxin A4 on gentamicin-induced nephrotoxicity in rats: The role of TNFα, TGF-β, ICAM-1, and JNK signaling.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antioxidants; Caspase 3; Creatinine; Gentamicins; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipoxins; Male; Malondialdehyde; Nitrites; Rats; Rats, Wistar; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Urea | 2022 |